High density lipoprotein and coronary artery disease risk factors in children with different lipoprotein profiles: Bogalusa Heart Study. 1985

D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson

Serum high density lipoprotein-cholesterol (HDL-C) and apoprotein A-1 (apo A-1) profiles were examined in subgroups of children (n = 338), initially aged 2-14 years, whose earlier beta-lipoprotein cholesterol (beta-LPC) and pre-beta-lipoprotein cholesterol (pre-beta-LPC) measurements were in extreme percentiles of values from a biracial community. Relationships of HDL-C and apo A-1 to serum lipoprotein lipids, apoprotein B (apo B), subscapular skinfold thickness, fasting and 1/2 hr postglucose plasma insulin, and fasting and 1 hr postglucose plasma glucose and free fatty acids were examined. Clustering of several coronary artery disease risk factors in these children was observed. HDL-C levels tended to be low in children having high pre-beta-LPC levels and apo A-1 levels were low in boys having high pre-beta-LPC levels. Within beta- and pre-beta-LPC strata, differences were also observed with respect to race, but not sex, in the mean levels of both HDL-C and apo A-1. HDL-C and apo A.1 were related inversely to subscapular skinfold thickness and plasma insulin levels in all children except those with low levels of both beta-LPC and pre-beta-LPC. Ratios of low density lipoprotein-cholesterol/HDL-C and of apo B/apo A-1 were related positively with other coronary artery disease risk factors except in children having low levels of both beta-LPC and pre-beta-LPC. The magnitude of these associations was greater in whites than in blacks. These observations may help to identify, at an early age, children at high risk of developing coronary artery disease in adulthood.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008145 Louisiana State bounded by Arkansas on the north, by Mississippi on the east, the Gulf of Mexico on the south and Texas on the west.
D008297 Male Males
D001741 Black or African American A person having origins in any of the black racial groups of Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. African American,African Americans,African-American,Afro-American,Afro-Americans,Black Americans,Blacks,Negroes,African-Americans,Negro,Afro American,Afro Americans,American, African,American, Black,Black American
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
December 1995, The American journal of the medical sciences,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
May 1979, Preventive medicine,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
May 1981, British medical journal (Clinical research ed.),
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
August 1984, Metabolism: clinical and experimental,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
January 1979, Lipids,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
January 2007, The American journal of cardiology,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
September 1990, The American journal of cardiology,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
September 2004, Current atherosclerosis reports,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
September 2002, Pediatrics,
D S Freedman, and S R Srinivasan, and A W Voors, and L S Webber, and G S Berenson
December 2015, Journal of proteome research,
Copied contents to your clipboard!